| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Osteoprotegerin, His (OPG Human) |
|---|
| Description | MW: 46,026 Da. Osteoprotegerin, which is a member of the tumor necrosis factor receptor superfamily and is involved in the regulation of bone metabolism. OPGand its ligand (OPGL) are cytokines regulating osteoclasto-genesis. OPGL binds to receptors on the surface of preosteoclasts and stimulates their differentiation into active osteoclasts. This leads to osteoresorption. OPG inhibits this osteoclasto-genesis (OPG is secreted by osteoblasts, and binds to OPGL, thus inhibiting maturation of osteo |
|---|
| Size | 0.01 mg, 0.05 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [osteoprotegerin; Tumor necrosis factor receptor superfamily member 11B; tumor necrosis factor receptor superfamily member 11B; tumor necrosis factor receptor superfamily member 11b; Osteoclastogenesis inhibitory factor; Osteoprotegerin] |
|---|
| Gene, Accession, CAS # | OPG, Gene ID: 4982, Accession: AAB53709.1 |
|---|
| Catalog # | MBS555525 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Osteoprotegerin, His (OPG Human) from MYBIOSOURCE INC. |
|---|
| Product Specific References | 1. Effects of hypolipemic drugs on the osteoprotegerin - sRANKL system in patients with coronary artery disease. Thromb Haemost 2007 May;97(5):868-702. Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function. Hypertension 2007 Jun;49(6):1392-83. The sex-specific association of serum osteoprotegerin and receptor activator of nu clear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study. Eur J Endo |
|---|
| 产品资料 |
|
|